W. Janowski

Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion

P. Ganly, S. Opat, C. Tam, 2020, Haematologica.

Teclistamab in Combination with Subcutaneous Daratumumab and Lenalidomide in Patients with Multiple Myeloma: Results from One Cohort of MajesTEC-2, a Phase1b, Multicohort Study

J. Goldberg, C. Touzeau, C. Hulin, 2022, Blood.

DREAMM-9: Phase I Study of Belantamab Mafodotin Plus Standard of Care in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma

S. Usmani, C. Min, B. Kremer, 2021, Blood.